These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21435322)

  • 1. Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR-ribotypes 012, 017 and 046 in Sweden, 2008 and 2009.
    Akerlund T; Alefjord I; Dohnhammar U; Struwe J; Noren T; Tegmark-Wisell K;
    Euro Surveill; 2011 Mar; 16(10):. PubMed ID: 21435322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.
    Ilchmann C; Zaiss NH; Speicher A; Christner M; Ackermann G; Rohde H
    Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1571-3. PubMed ID: 20632051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes.
    Freeman J; Vernon J; Morris K; Nicholson S; Todhunter S; Longshaw C; Wilcox MH;
    Clin Microbiol Infect; 2015 Mar; 21(3):248.e9-248.e16. PubMed ID: 25701178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of Clostridium difficile in Scotland.
    Wiuff C; Brown DJ; Mather H; Banks AL; Eastaway A; Coia JE
    J Infect; 2011 Apr; 62(4):271-9. PubMed ID: 21300104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in antibiotic susceptibility and ribotypes in Clostridium difficile isolates from southern Scotland, 1979-2004.
    Taori SK; Hall V; Poxton IR
    J Med Microbiol; 2010 Mar; 59(Pt 3):338-344. PubMed ID: 19942691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.
    Carman RJ; Genheimer CW; Rafii F; Park M; Hiltonsmith MF; Lyerly DM
    Anaerobe; 2009 Dec; 15(6):244-8. PubMed ID: 19818865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.
    Spigaglia P; Barbanti F; Dionisi AM; Mastrantonio P
    J Clin Microbiol; 2010 Aug; 48(8):2892-6. PubMed ID: 20554809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
    Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
    Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain.
    Huang H; Weintraub A; Fang H; Nord CE
    Scand J Infect Dis; 2009; 41(2):158-9. PubMed ID: 18846478
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
    Lachowicz D; Pituch H; Obuch-Woszczatyński P
    Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm.
    Huang H; Fang H; Weintraub A; Nord CE
    Clin Microbiol Infect; 2009 Dec; 15(12):1170-3. PubMed ID: 19624517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
    Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
    Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
    Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
    Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates.
    Solomon K; Fanning S; McDermott S; Murray S; Scott L; Martin A; Skally M; Burns K; Kuijper E; Fitzpatrick F; Fenelon L; Kyne L
    J Antimicrob Chemother; 2011 Sep; 66(9):1976-82. PubMed ID: 21712239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.
    Drudy D; Quinn T; O'Mahony R; Kyne L; O'Gaora P; Fanning S
    J Antimicrob Chemother; 2006 Dec; 58(6):1264-7. PubMed ID: 17018563
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Freeman J; Pilling S; Vernon J; Wilcox MH
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization and antimicrobial susceptibility patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland.
    Mutlu E; Wroe AJ; Sanchez-Hurtado K; Brazier JS; Poxton IR
    J Med Microbiol; 2007 Jul; 56(Pt 7):921-929. PubMed ID: 17577057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027.
    Krutova M; Nyc O; Matejkova J; Kuijper EJ; Jalava J; Mentula S
    J Microbiol Immunol Infect; 2018 Jun; 51(3):344-351. PubMed ID: 28583353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.
    Walkty A; Boyd DA; Gravel D; Hutchinson J; McGeer A; Moore D; Simor A; Suh K; Taylor G; Miller M; Mulvey MR;
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):419-24. PubMed ID: 20226332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.